As the global population continues to age in early 2026, biosimilars are playing a crucial role in managing age-related conditions like osteoporosis and macular degeneration more affordably. For seniors living on fixed incomes, the high cost of brand-name "Bone-Building" or "Sight-Saving" injections has often been a major financial stressor. In early 2026, the introduction of biosimilars for...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china